Rekombinanter GDF8 (Lintuzumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter GDF8 (Lintuzumab Biosimilar) Antikörper (ABIN7543068)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-CD33 [SGN-33 (Lintuzumab)], Human IgG1, kappa
-
Spezifität
- This antibody is specific for human CD33, which is restricted to cells of the myelomonocytic lineage. CD33 but does not appear in abundance on normal cells, but is over-expressed in AML and other myeloproliferative diseases.
-
Produktmerkmale
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
Aufreinigung
- Protein A affinity purified
-
Immunogen
- This humanized antibody was prepared by combining the CDR regions of the murine anti-CD33 M195 with human framework and constant regions.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- In vitro, this antibody is capable of mediating ADCC against AML cells (Caron, 1998). Though shown to be safe in phase III trials, the use of this antibody in combination with induction chemotherapy did not result in a statistically significant improvement in response rate or survival in patients with refractory/relapsed AML (Feldman, 2005).
-
Kommentare
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- GDF8 (Lintuzumab Biosimilar)
-
Andere Bezeichnung
- CD33 (Lintuzumab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
- Sialic acid-binding Ig-like lectin 3, gp67, HuM195
-
UniProt
- P20138
Target
-